 intraven immunoglobulin therapi prevent infect high-risk prematur infant report multicent double-blind studi effect immunoglobulin Ig therapi prophylaxi infect high-risk preterm infant thirty-f prematur newborn double-blind trial treatment placebo group thirty-f infant Ig group placebo group episod certain infect thirti infant Ig group placebo group episod probabl infect signific differ incid certain probabl infect treat control infant nevertheless infant certain probabl episod infect Ig group placebo group possibl deleteri effect administr larg amount polyspecif Ig